Get 3 full articles or in-depth documentaries for free! Click here

Australian government says vaccine risk too high for people under 30

Mike Campbell

November 14, 2022

The Australian government says the risk of myocarditis from a COVID booster might be greater than COVID itself — so it won’t allow people under 30 to get a fourth vaccine.

Australian government says vaccine risk too high for people under 30
Australian government says vaccine risk too high for people under 30.

“In males aged 16-40 years, it is uncertain whether the risk following COVID-19 remains higher than the risk following vaccination,” the government said.

The government considers myocarditis and pericarditis following COVID vaccination severe enough to warrant a 13-page guideline. The guideline is updated regularly. 

“The majority of cases of myocarditis reported after COVID-19 vaccines have occurred in males under 40, and the majority have occurred within 1-5 days (median 2 days) following the second dose of an mRNA vaccine. Myo/pericarditis is more common after the second dose of Moderna compared with second doses of Pfizer and AstraZeneca.”

The guidance further states that there are no studies on the long-term dangers of myocarditis following COVID vaccination. The government says most cases result in hospitalization and some in death.

Last week, Pfizer and Moderna launched clinical trials to study the long-term effects of myocarditis following vaccination with its mRNA vaccines. The launch comes roughly 18 months after the products went to market with a promise of being “safe and effective.”

NBC News reports that the Food and Drug Administration (FDA) required the drugmakers to conduct the study. It was needed as part of the emergency-use approval process that allowed the drugs to go to market before clinical trials were completed. 

In July, Ontario Chief Medical Officer Kieran Moore announced that a fourth vaccine is now available for everyone over 18. However, he said not everyone should get another vaccine due to the risk of myocarditis. 

Moore also suggested the “vaccine” is therapeutic.

“There’s always a risk to having any therapeutic versus a benefit. You want to make sure there’s a very strong benefit versus the risk. If you’re an 18-year-old healthy individual, the risk of getting hospitalized if you have no underlying medical illness is very, very low,” Moore said.

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

The WHO has stopped advising that healthy children and teens get the COVID vaccine but not pregnant women.

TCS Wire

March 30, 2023

Trending News

Western Australia’s government gave police back ‘temporary’ powers that it had during the COVID pandemic, but this time to stop drug trafficking — until 2028.

Mike Campbell

March 29, 2023

Trending News

Conservative Party leader Pierre Poilievre told reporters on Friday that he asked President Biden to scrap the US travel ban that still exists on unvaccinated Canadians.

Mike Campbell

March 24, 2023

Trending News

US President Biden accidentally called Canada “China” on Friday in the House of Commons, just one day after Canadian MPs voted in favour of a public inquiry to look into just how much China runs Canada.

TCS Wire

March 24, 2023

Trending News

Moderna’s CEO feigned ignorance when asked by Republican Senator Rand Paul if he knew of young males having an increased risk of myocarditis when they get COVID vaccinated compared to infected. 

Mike Campbell

March 22, 2023

Trending News

Bill Gates said support for the World Health Organization is needed to establish a Global Health Emergency Corps for “the next pandemic.”

Mike Campbell

March 20, 2023

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.